Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03794661 · ClinicalTrials.gov registry record · NA
Evaluation of the Infinity Deep Brain Stimulation Electrode Screening Mode Tool
A NA study, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT03794661 is a NA study that has completed, run by Abbott Medical Devices. The registered enrollment target is 8 participants.
The verdict
NCT03794661, a NA study, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The objective of this clinical investigation is to characterize the clinical performance of Abbott's Clinician Programmer Electrode Screening Mode tool (InformityTM tool) in programming InfinityTM deep brain stimulation (DBS) systems for patients with Parkinson's disease (PD) or essential tremor (ET).
Interventions
- DEVICE Clinician programmer electrode screening mode tool
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2019-06-26 |
| Est. Completion | 2020-12-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03794661
The ClinicalTrials.gov registry entry for NCT03794661 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Clinician programmer electrode screening mode tool is the first listed.
NCT03794661 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03794661 about?
NCT03794661 is a clinical study titled "Evaluation of the Infinity Deep Brain Stimulation Electrode Screening Mode Tool". The objective of this clinical investigation is to characterize the clinical performance of Abbott's Clinician Programmer Electrode Screening Mode tool (InformityTM tool) in programming InfinityTM deep brain stimulation (DBS) systems for patients with Parkinson's disease (PD) or essential tremor (ET...
What is the current status of trial NCT03794661?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2019-06-26. Estimated completion is 2020-12-16.
What interventions are being tested in trial NCT03794661?
The interventions under investigation include: Clinician programmer electrode screening mode tool (DEVICE).
Who is sponsoring clinical trial NCT03794661?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.